Australia's largest stock trading and investment forum Australia's #1 stock forum

Sudden Adult Death Syndrome baffles doctors, page-2

First 2 Last

Share
Profile

Follow
sahmee

9,019 Posts.

535

28/06/22

15:37

Post #: 62252353
Share

Originally posted by crackpot: ↑

https://spectator.com.au/2022/06/sudden-adult-death-syndrome-baffles-doctors/
A strange new medical anomaly has doctors baffled as it sweeps across the country. Sudden Adult Death Syndrome (SADS) is on the rise, and it’s tragically claiming the lives of healthy young adults, sometimes in their sleep.
Essentially, people are dying without displaying any prior sign of illness. They simply do not wake up after going to bed, or collapse during the day.
Reports of SADS have been increasing in recent weeks. A news.com web explains that, ‘Sudden Adult Death Syndrome … is an umbrella term to describe unexpected deaths in young people, usually under 40, when a post-mortem can find no obvious cause of death.’
The Melbourne-basedBaker Heart and Diabetes Institutehopes to roll out a nation-wide registry to track cases.
Apparently, SADS is now so common that the medical authorities must quickly develop a national registry to track SADS cases.
A Health Desk published on June 7 notes that, ‘Most scientists think SADS is caused by a heart condition that interferes with the heart’s electrical system.’
Ah, so it’s a heart condition. Interesting.
It’s unfortunate that no sooner have we gone through a pandemic that a condition synonymous with ‘people dying of heart conditions for no apparent reason’ is on the rise. Is this simply terrible luck for the human species, or did something happen between the beginning of Covid and the emergence of this new epidemic that might explain it? In other words, what changed between then and now that might be affecting people’s hearts? Surely, any rational, objective, and truth-seeking person would ask this question…

Except, questions are becoming increasingly difficult to ask in a censorial medical world protective of its assets.
We are not really allowed to ask if these deaths in otherwise healthy young adults have anything to do with the last two years of abnormal health orders or the entry onto the market of new technology with limited long-term safety information.
What we do know is that mRNA vaccines have been linked to an alarming amount of deaths during a three-month trial period conducted by Pfizer in documents that they sought to suppress for 75 years – a request that was denied by the judge.
We also know that these vaccines are officially – according to vaccine safety regulators, manufacturers, and investigations conducted between 2020-22 – connected to a rise in cardiac problems such as myocarditis and pericarditis, along with a range of other health issues including neurological disorders and sometimes death.
The New York Times previously published an article discussing the link:
It is also true that Australian healthcare professionals werenot to undermine the Covid vaccine program in any way lest they lose their medical licenses.
These are the same vaccines that were mandated by public health order or corporate directions, resulting in over 90 per cent of the adult population taking at least one (but almost certainly two or more) doses within the last couple of years.
It is becoming increasingly obvious where we should be looking when it comes to all these ‘co-incidental’ spikes in diseases and deaths that have come out of nowhere in the last two years. If we were approaching science objectively and rationally, it would be permissible to ask questions of vaccine manufacturers – even if only to rule them out, once and for all, as the culprit.
However, these are not solely questions of science, but also of money, business, and political reputation. Organisations such as the TGA have not exactly been eager to investigate situations that could call into question their previous judgment (even though they have a history of making mistakes regarding medical safety).
Instead, we are being told to accept the sudden rise in SADS and the deaths of young people without investigation. After all, no one wants to be called a conspiracy theorist or an anti-vaxxer.
The Health Desk article mentioned above anticipates the questions of the ‘conspiracy theorists’ and explains:
If this is meant to inspire confidence in the Covid vaccines, it does a poor job.
Myocarditis is not ‘extremely rare’ after a Covid vaccination in the way that childhood vaccines produced almost unheard of side effects. Even if the TGA’s figures related to Covid vaccines and heart conditions are taken at face value despite complaints of missing data, it’s that developing heart-related conditions after receiving a Covid vaccine is common enough to warrant some countries to put age limits on certain brands.
The missing information that would help to clear this situation up would be the vaccination status of those who are tragically dying to clear up whether it really is a Covid infection (as explained away by some medical journals) or vaccination.
People don’t die without any cause at all, yet the past year or so has seen a lot of people ‘die suddenly’, often from heart attacks, have you noticed? It is not only in Australia. These rises are being seen across the Western world causing enough concern to warrant medical investigations.
If we care about truth at all, these questions have to be asked.

Expand

you're political apathy has put at risk everything you think you have.
3 Upvote

Reply

Top Stories

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

VYS

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

TBN

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

HVN

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

PYC

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

CCO

The Calmer Co’s Anthony Noble reflects on record breaking FY24

LLC

Lendlease sells off US east coast construction operations in latest global divestment push

CYM

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

HLX

Helix investor makes partial takeover bid, proposing board changes

There are more pages in this discussion • 79 more messages in this thread...

First 2 Last

Sudden Adult Death Syndrome baffles doctors, page-2

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

The Calmer Co’s Anthony Noble reflects on record breaking FY24

Lendlease sells off US east coast construction operations in latest global divestment push

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

Helix investor makes partial takeover bid, proposing board changes

Featured News

Featured News

Sudden Adult Death Syndrome baffles doctors, page-2

Top Stories

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

The Calmer Co’s Anthony Noble reflects on record breaking FY24

Lendlease sells off US east coast construction operations in latest global divestment push

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

Helix investor makes partial takeover bid, proposing board changes

Featured News

Featured News